| pubmed-article:17566844 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17566844 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:17566844 | lifeskim:mentions | umls-concept:C1556094 | lld:lifeskim |
| pubmed-article:17566844 | lifeskim:mentions | umls-concept:C0677886 | lld:lifeskim |
| pubmed-article:17566844 | lifeskim:mentions | umls-concept:C0031928 | lld:lifeskim |
| pubmed-article:17566844 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:17566844 | pubmed:dateCreated | 2007-6-14 | lld:pubmed |
| pubmed-article:17566844 | pubmed:abstractText | It has been reported that a docetaxel-carboplatin combination as first-line chemotherapy for ovarian cancer showed a level of progression-free survival similar to that of paclitaxel-carboplatin while reducing neurotoxicity and improving quality of life. We investigated the recommended doses of docetaxel-carboplatin in Japanese patients with ovarian cancer and conducted a comparative study of docetaxel-carboplatin versus paclitaxel-carboplatin. | lld:pubmed |
| pubmed-article:17566844 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17566844 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17566844 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17566844 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17566844 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17566844 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17566844 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17566844 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17566844 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:17566844 | pubmed:issn | 1341-9625 | lld:pubmed |
| pubmed-article:17566844 | pubmed:author | pubmed-author:FujitaHiroyuk... | lld:pubmed |
| pubmed-article:17566844 | pubmed:author | pubmed-author:KatoYoshikoY | lld:pubmed |
| pubmed-article:17566844 | pubmed:author | pubmed-author:HonjoHideoH | lld:pubmed |
| pubmed-article:17566844 | pubmed:author | pubmed-author:NakataYoshino... | lld:pubmed |
| pubmed-article:17566844 | pubmed:author | pubmed-author:HosokawaKenic... | lld:pubmed |
| pubmed-article:17566844 | pubmed:author | pubmed-author:YamaguchiTake... | lld:pubmed |
| pubmed-article:17566844 | pubmed:author | pubmed-author:MoriTaisukeT | lld:pubmed |
| pubmed-article:17566844 | pubmed:author | pubmed-author:YasudaJinsuke... | lld:pubmed |
| pubmed-article:17566844 | pubmed:author | pubmed-author:KuroboshiHaru... | lld:pubmed |
| pubmed-article:17566844 | pubmed:author | pubmed-author:KinoshitaYosh... | lld:pubmed |
| pubmed-article:17566844 | pubmed:author | pubmed-author:WatanabeAiA | lld:pubmed |
| pubmed-article:17566844 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17566844 | pubmed:volume | 12 | lld:pubmed |
| pubmed-article:17566844 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17566844 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17566844 | pubmed:pagination | 205-11 | lld:pubmed |
| pubmed-article:17566844 | pubmed:meshHeading | pubmed-meshheading:17566844... | lld:pubmed |
| pubmed-article:17566844 | pubmed:meshHeading | pubmed-meshheading:17566844... | lld:pubmed |
| pubmed-article:17566844 | pubmed:meshHeading | pubmed-meshheading:17566844... | lld:pubmed |
| pubmed-article:17566844 | pubmed:meshHeading | pubmed-meshheading:17566844... | lld:pubmed |
| pubmed-article:17566844 | pubmed:meshHeading | pubmed-meshheading:17566844... | lld:pubmed |
| pubmed-article:17566844 | pubmed:meshHeading | pubmed-meshheading:17566844... | lld:pubmed |
| pubmed-article:17566844 | pubmed:meshHeading | pubmed-meshheading:17566844... | lld:pubmed |
| pubmed-article:17566844 | pubmed:meshHeading | pubmed-meshheading:17566844... | lld:pubmed |
| pubmed-article:17566844 | pubmed:meshHeading | pubmed-meshheading:17566844... | lld:pubmed |
| pubmed-article:17566844 | pubmed:meshHeading | pubmed-meshheading:17566844... | lld:pubmed |
| pubmed-article:17566844 | pubmed:meshHeading | pubmed-meshheading:17566844... | lld:pubmed |
| pubmed-article:17566844 | pubmed:meshHeading | pubmed-meshheading:17566844... | lld:pubmed |
| pubmed-article:17566844 | pubmed:meshHeading | pubmed-meshheading:17566844... | lld:pubmed |
| pubmed-article:17566844 | pubmed:meshHeading | pubmed-meshheading:17566844... | lld:pubmed |
| pubmed-article:17566844 | pubmed:meshHeading | pubmed-meshheading:17566844... | lld:pubmed |
| pubmed-article:17566844 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17566844 | pubmed:articleTitle | A pilot study of docetaxel-carboplatin versus paclitaxel-carboplatin in Japanese patients with epithelial ovarian cancer. | lld:pubmed |
| pubmed-article:17566844 | pubmed:affiliation | Department of Obstetrics and Gynecology, Kyoto Prefectural University of Medicine, Kawaramachi Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan. | lld:pubmed |
| pubmed-article:17566844 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17566844 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:17566844 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17566844 | lld:pubmed |
